| Literature DB >> 35522461 |
HyoRim Ju1, EunKyo Kang2, YoungIn Kim3, HyunYoung Ko3, Belong Cho1.
Abstract
BACKGROUND: As the global burden of chronic conditions increases, their effective management is a concern. Although the need for chronic disease management using mobile self-management health care apps is increasing, there are still many barriers to their practical application in the primary care field.Entities:
Keywords: app; chronic conditions; health care; healthcare; mobile application; primary care; self-management
Mesh:
Year: 2022 PMID: 35522461 PMCID: PMC9123543 DOI: 10.2196/34531
Source DB: PubMed Journal: JMIR Mhealth Uhealth ISSN: 2291-5222 Impact factor: 4.947
Figure 1Example to track their daily activity, food intake, blood pressure, and blood sugar and chat human coaching.
Demographic and clinical characteristics of participants (N=110).
| Demographic description | Intervention group (n=65) | Control group (n=45) | |||
| Age (years), mean (SD) | 51.93 (8.06) | 55.24 (10.46) | .08 | ||
|
| .39 | ||||
|
| Male | 25 (38.46) | 21 (46.67) |
| |
|
| Female | 40 (61.54) | 24 (53.33) |
| |
|
| .07 | ||||
|
| High school or lower | 32 (49.23) | 30 (66.67) |
| |
|
| College or university | 33 (50.77) | 15 (33.33) |
| |
|
| .36 | ||||
|
| Hypertension | 22 (34.00) | 15 (33.00) |
| |
|
| Diabetes mellitus | 35 (54.00) | 24 (53.00) |
| |
|
| Hyperlipidemia | 3 (5.00) | 3 (7.00) |
| |
|
| Metabolic syndrome | 5 (8.00) | 6 (13.00) |
| |
Changes in clinical characteristics after 12 weeks.
| Clinical characteristics | Intervention group (n=65), mean (SD) | Control group (n=45), mean (SD) | ||||||
| <.001 | .63 | |||||||
|
| Baseline | 78.10 (17.46) |
| 74.05 (15.30) |
| |||
|
| After 12 weeks | 76.67 (17.10) |
| 73.92 (15.03) |
| |||
|
| <.001 |
| .72 | |||||
|
| Baseline | 3.12 (1.00) |
| 3.20 (0.89) |
| |||
|
| After 12 weeks | 3.49 (0.95) |
| 3.15 (0.87) |
| |||
|
| <.001 |
| .65 | |||||
|
| Baseline | 6.23 (1.17) |
| 6.18 (1.04) |
| |||
|
| After 12 weeks | 6.59 1.12 |
| 6.14 (1.12) |
| |||
|
| .12 |
| .25 | |||||
|
| Baseline | 43.17 (4.51) |
| 43.91 (4.63) |
| |||
|
| After 12 weeks | 43.94 (5.01) |
| 44.86 (4.82) |
| |||
|
| .12 |
| .03 | |||||
|
| Baseline | 39.91 (5.56) |
| 38.46 (5.98) |
| |||
|
| After 12 weeks | 41.04 (4.97) |
| 40.83 (7.60) |
| |||
|
| .87 |
| .86 | |||||
|
| Baseline | 1.29 (1.71) |
| 0.88 (1.54) |
| |||
|
| After 12 weeks | 1.26 (1.53) |
| 0.93 (1.48) |
| |||
|
| .26 |
| .49 | |||||
|
| Baseline | 1.16 (1.68) |
| 0.80 (1.37) |
| |||
|
| After 12 weeks | 0.98 (1.52) |
| 0.66 (1.39) |
| |||
|
| .01 |
| .92 | |||||
|
| Baseline | 16.38 (6.89) |
| 14.02 (5.61) |
| |||
| After 12 weeks | 14.43 (5.9) | 14.11 (6.03) | ||||||
Changes in physical and laboratory measurements after 12 weeksa.
| Measurements | Intervention group (n=42), mean (SD) | Control group (n=24), mean (SD) | ||||||
|
| .03 | .53 | ||||||
|
| Baseline | 93.41 (11.09) |
| 89.99 (9.08) |
| |||
|
| After 12 weeks | 91.75 (11.57) |
| 89.64 (9.14) |
| |||
|
| .04 |
| .66 | |||||
|
| Baseline | 28.60 (4.47) |
| 27.65 (4.12) |
| |||
|
| After 12 weeks | 27.83 (4.23) |
| 27.58 (4.04) |
| |||
|
| .09 |
| .76 | |||||
|
| Baseline | 123.95 (12.35) |
| 127.75 (12.02) |
| |||
|
| After 12 weeks | 127.02 (15.00) |
| 126.75 (10.77) |
| |||
|
| .06 |
| .76 | |||||
|
| Baseline | 77.71 (7.83) |
| 77.87 (8.30) |
| |||
|
| After 12 weeks | 81.19 (11.51) |
| 78.37 (9.70) |
| |||
|
| .04 |
| .89 | |||||
|
| Baseline | 6.69 (1.06) |
| 6.73 (0.94) |
| |||
|
| After 12 weeks | 6.51 (0.91) |
| 6.72 (0.93) |
| |||
|
| .83 |
| .73 | |||||
|
| Baseline | 165.80 (46.49) |
| 159.29 (36.22) |
| |||
|
| After 12 weeks | 167.26 (35.68) |
| 157.08 (41.57) |
| |||
|
| .02 |
| .67 | |||||
|
| Baseline | 48.50 (11.30) |
| 47.17 (10.82) |
| |||
|
| After 12 weeks | 51.23 (12.36) |
| 47.78 (8.04) |
| |||
|
| .37 |
| .54 | |||||
|
| Baseline | 85.83 (30.32) |
| 78.73 (30.13) |
| |||
|
| After 12 weeks | 89.49 (30.97) |
| 76.01 (35.83) |
| |||
|
| .003 |
| .47 | |||||
|
| Baseline | 176.38 (109.02) |
| 193.33 (199.90) |
| |||
| After 12 weeks | 136.07 (54.2) | 166.37 (60.93) | ||||||
aAll physical and laboratory measurements were obtained at the participating primary care center and only for a subset of participating patients as judged necessary by the primary care physicians. Hence, this table shows only 42 and 24 participants in the intervention and control groups, respectively.
Comparison of measurements changes between baseline and after 12 weeks by the group.
| Measurements | Intervention group (n=65), mean (SD) | Control group (n=45), mean (SD) | |
| Body weight (kg) | –1.43 (2.59) | –0.13 (1.78) | .002 |
| Sleep quality score | 0.36 (0.71) | –0.04 (0.82) | .007 |
| Sleep duration (hours) | 0.35 (0.78) | –0.04 (0.64) | .004 |
| Short-Form-12 Health Survey (physical composite) score | 1.91 (5.64) | 0.94 (5.44) | .37 |
| Short-Form-12 Health Survey (mental composite) score | 1.12 (5.74) | 2.37 (7.21) | .34 |
| Patient Health Questionnaire-2 score | –0.03 (1.46) | 0.04 (1.71) | .81 |
| Generalized Anxiety Disorder-2 scale score | –0.18 (1.30) | –0.13 (1.27) | .84 |
| Propensity score | –1.95 (6.01) | 0.08 (5.99) | .08 |
| Waist circumference (cm)a | –1.82 (4.53) | –0.15 (3.59) | .04 |
| BMI (kg/m2)a | –0.53 (0.99) | –0.04 (0.64) | .002 |
| Systolic blood pressure (mm Hg)a | 3.35 (11.02) | 1.23 (17.36) | .51 |
| Diastolic blood pressure (mm Hg)a | 3.23 (11.34) | 0.05 (8.78) | .14 |
| Hemoglobin A1c levels (%)a | –0.17 (0.60) | –0.01 (0.42) | .14 |
| Total cholesterol levels (mg/dl)a | 4.09 (42.65) | –0.82 (27.43) | .52 |
| High-density lipoprotein cholesterol levels (mg/dL)a | 3.16 (7.10) | 2.03 (6.99) | .47 |
| Low-density lipoprotein cholesterol levels (mg/dL)a | 6.99 (30.85) | –0.94 (20.28) | .16 |
| Triglyceride levels (mg/dL)a | –37.94 (89.18) | –51.05 (182.82) | .70 |
aAll physical and laboratory measurements were obtained at the participating primary center and only for a subset of participating patients (intervention group, n=42; control group, n=24) as judged necessary by the primary care physicians.
Comparison of measurements change between baseline and after 3 months by app use period.
| Measurements | Control group (n=45), mean (SD) | Intervention group (n=65), mean (SD) | ||||
|
| Less than 4 weeks (n=18) | 5-8 weeks (n=11) | Greater than 9 weeks (n=36) |
| ||
| Body weight (kg) | –0.13 (1.78) | –0.90 (1.75) | –0.33 (1.55) | –2.02 (3.03) | .002 | |
| Sleep quality score | –0.04 (0.82) | 0.16 (0.38) | 0.27 (0.46) | 0.50 (0.87) | .02 | |
| Sleep duration (hours) | –0.04 (0.64) | 0.25 (0.55) | 0.36 (0.77) | 0.40 (0.89) | .045 | |
| Waist circumference (cm) | –0.15 (3.59) | –1.18 (1.93) | –1.37 (1.93) | –2.21 (5.84) | .22 | |
| BMI (kg/m2) | –0.04 (0.64) | –0.33 (0.69) | –0.13 (0.64) | –0.75 (1.15) | .003 | |